Alignment Healthcare, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Alignment Healthcare, Inc. (ALHC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ALHC insiders buying or selling?
In the last 12 months, Alignment Healthcare, Inc. insiders reported 1 open-market purchase ($197.6K) and 60 sales ($521.1M) — net selling of $520.9M. Since April 2021, Trabud has recorded 302 Form 4 filings for ALHC: 3 buys ($1.4M) and 299 sells ($2.8B).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $197.6K by Mark D. Kent (President - MSO) on Jun 2, 2026. SEC ↗
- The most recent open-market purchase was reported on Jun 2, 2026 (4 months ago).
Key Statistics (April 2021 – Oct 7, 2026)
Total Form 4 filings
302
SEC EDGAR
Insider filers
23
Insider buys (3)
$1.4M
Insider sells (299)
$2.8B
Insider sentiment
Net sellingNet insider flow of $2.8B in net selling since April 2021, and $520.9M in net selling over the last 12 months.
Recent ALHC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Hyong Kim | Chief Medical Officer | Sale | 32.5K | $8.30 | $269.6K | SEC ↗ |
| Sep 18, 2026 | Joseph S Konowiecki | EVP, Corporate Affairs | Sale | 23.5K | $8.61 | $202.4K | SEC ↗ |
| Sep 16, 2026 | John E Kao | Chief Executive Officer | Sale | 27.4K | $13.00 | $356.2K | SEC ↗ |
| Sep 12, 2026 | Dawn Christine Maroney | President | Sale | 122.7K | $12.68 | $1.6M | SEC ↗ |
| Sep 12, 2026 | John E Kao | Chief Executive Officer | Sale | 557.9K | $12.77 | $7.1M | SEC ↗ |
| Aug 18, 2026 | Dawn Christine Maroney | President | Sale | 5.0K | $14.00 | $70.0K | SEC ↗ |
| Aug 10, 2026 | John E Kao | Chief Executive Officer | Sale | 298.0K | $13.88 | $4.1M | SEC ↗ |
| Jul 16, 2026 | Dawn Christine Maroney | President | Sale | 177.1K | $20.83 | $3.7M | SEC ↗ |
| Jul 14, 2026 | John E Kao | Chief Executive Officer | Sale | 298.0K | $19.86 | $5.9M | SEC ↗ |
| Jul 1, 2026 | Joseph S Konowiecki | EVP, Corporate Affairs | Sale | 25.0K | $24.00 | $600.0K | SEC ↗ |
| Jun 26, 2026 | Joseph S Konowiecki | EVP, Corporate Affairs | Sale | 25.0K | $23.00 | $575.0K | SEC ↗ |
| Jun 18, 2026 | Joseph S Konowiecki | EVP, Corporate Affairs | Sale | 25.0K | $22.00 | $550.0K | SEC ↗ |
| Jun 15, 2026 | Dawn Christine Maroney | President | Sale | 30.0K | $19.55 | $586.4K | SEC ↗ |
| Jun 15, 2026 | Hyong Kim | Chief Medical Officer | Sale | 36.0K | $19.86 | $713.9K | SEC ↗ |
| Jun 12, 2026 | Joseph S Konowiecki | EVP, Corporate Affairs | Sale | 25.0K | $21.00 | $525.0K | SEC ↗ |
| Jun 12, 2026 | John E Kao | Chief Executive Officer | Sale | 298.0K | $20.36 | $6.1M | SEC ↗ |
| Jun 2, 2026 | Mark D. Kent | President - MSO | Purchase | 14.8K | $13.31 | $197.6K | SEC ↗ |
| May 19, 2026 | Dawn Christine Maroney | President | Sale | 30.0K | $16.09 | $482.6K | SEC ↗ |
| May 13, 2026 | John E Kao | Chief Executive Officer | Sale | 298.0K | $16.89 | $5.0M | SEC ↗ |
| Apr 16, 2026 | Dawn Christine Maroney | President | Sale | 30.0K | $20.87 | $626.2K | SEC ↗ |
| Apr 13, 2026 | John E Kao | Chief Executive Officer | Sale | 298.0K | $20.68 | $6.2M | SEC ↗ |
| Apr 8, 2026 | James M Head | Chief Financial Officer | Sale | 11.1K | $21.08 | $234.0K | SEC ↗ |
| Apr 8, 2026 | John E Kao | Chief Executive Officer | Sale | 250.0K | $21.01 | $5.3M | SEC ↗ |
| Apr 1, 2026 | Christopher J Joyce | Chief Legal and Admin. Officer | Sale | 18.0K | $17.79 | $320.5K | SEC ↗ |
| Mar 23, 2026 | John E Kao | Chief Executive Officer | Sale | 118.0K | $17.48 | $2.1M | SEC ↗ |
Showing the 25 most recent of 302 Form 4 filings for Alignment Healthcare, Inc..
Most active ALHC insiders
- Dawn Christine Maroney55 filings
- John E Kao52 filings
- Robert Thomas Freeman32 filings
- Dinesh M. Kumar22 filings
- Christopher J Joyce20 filings
Ask anything about ALHC insider activity
Use Trabud's AI agent to query Alignment Healthcare, Inc.'s Form 4 history in plain English — "Show me ALHC CEO purchases this year" or compare it against any other ticker.
Open the AI agentALHC insider trading FAQ
Are Alignment Healthcare, Inc. insiders buying or selling?
In the last 12 months, Alignment Healthcare, Inc. insiders reported 1 open-market purchase ($197.6K) and 60 sales ($521.1M) — net selling of $520.9M. Since April 2021, Trabud has recorded 302 Form 4 filings for ALHC: 3 buys ($1.4M) and 299 sells ($2.8B). Over the full record that is net selling of $2.8B.
How many insiders trade ALHC stock?
23 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Alignment Healthcare, Inc.. The most recent filing was accepted on Oct 7, 2026.
Where does Trabud get ALHC insider trading data?
All ALHC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.